Mazzei G J, Seckinger P L, Dayer J M, Shaw A R
Glaxo Institute for Molecular Biology S.A., Geneva, Switzerland.
Eur J Immunol. 1990 Mar;20(3):683-9. doi: 10.1002/eji.1830200332.
The urine of patients with fever above 39 degrees C contains an inhibitor of interleukin 1. Herein we describe the purification of the interleukin 1 inhibitor by ion-exchange chromatography, hydrophobic chromatography, gel filtration and negative immunosorption. The purified protein has a molecular weight of 26,000; its size is reduced to 24,000 upon treatment with endoglycosidase F. The IL 1 inhibitor is a competitive inhibitor and acts by binding to the IL 1 receptor. The inhibitor recognizes the murine and human IL 1 receptor with similar affinity. The purified IL 1 inhibitor has a specific activity of 3 x 10(7) to 4.5 x 10(7) units/mg as tested on the human astrocytoma (U-373) cell proliferation bioassay and murine EL4.6.1 cell IL 1 receptor-binding assay.
体温高于39摄氏度的患者尿液中含有白细胞介素1的一种抑制剂。在此我们描述了通过离子交换色谱法、疏水色谱法、凝胶过滤法和阴性免疫吸附法对白细胞介素1抑制剂进行纯化的过程。纯化后的蛋白质分子量为26,000;用内切糖苷酶F处理后其大小降至24,000。白细胞介素1抑制剂是一种竞争性抑制剂,通过与白细胞介素1受体结合发挥作用。该抑制剂以相似的亲和力识别小鼠和人类白细胞介素1受体。经人星形细胞瘤(U - 373)细胞增殖生物测定和小鼠EL4.6.1细胞白细胞介素1受体结合测定,纯化后的白细胞介素1抑制剂的比活性为3×10⁷至4.5×10⁷单位/毫克。